Identification of patients with COVID-19 who are optimal for methylprednisolone pulse therapy

BACKGROUND: Corticosteroids have been reported to reduce the mortality rates in patients with coronavirus disease 2019 (COVID-19). Additionally, the role of high-dose methylprednisolone pulse therapy in reducing mortality in critically ill patients has also been documented. The purpose of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Ro, Shosei, Nishimura, Naoki, Imai, Ryosuke, Tomishima, Yutaka, So, Clara, Murakami, Manabu, Okafuji, Kohei, Kitamura, Atsushi, Jinta, Torahiko, Tamura, Tomohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273631/
https://www.ncbi.nlm.nih.gov/pubmed/34322232
http://dx.doi.org/10.4081/mrm.2021.781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273631/
https://www.ncbi.nlm.nih.gov/pubmed/34322232
http://dx.doi.org/10.4081/mrm.2021.781

Ejemplares similares